文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

氟哌啶醇减轻急诊胃轻瘫症状(HUGS)

Haloperidol undermining gastroparesis symptoms (HUGS) in the emergency department.
PubMed 文献 · Am J Emerg Med · 2017-03-12
一句话结论对于糖尿病继发胃轻瘫伴恶心、呕吐、腹痛的急诊患者,给予氟哌啶醇与降低吗啡等效镇痛剂量和减少因胃轻瘫住院相关。

本研究为回顾性自身对照研究,纳入52例因糖尿病继发胃轻瘫相关恶心、呕吐、腹痛就诊急诊并接受氟哌啶醇治疗的患者,与本人最近一次未接受氟哌啶醇的急诊就诊进行比较。结果显示,接受氟哌啶醇时吗啡等效镇痛剂量中位数显著降低(6.75 vs 10.75,P=0.001),因胃轻瘫住院比例显著降低(5/52 vs 14/52,P=0.02)。急诊停留时间、住院时间及追加止吐药方面无显著差异,未发现接受氟哌啶醇患者出现并发症。作者认为氟哌啶醇可能作为急诊胃轻瘫相关恶心、呕吐、腹痛的传统镇痛止吐治疗的一种合适、有效且安全的替代选择。

要点

  • 糖尿病继发胃轻瘫相关恶心、呕吐、腹痛急诊患者接受氟哌啶醇后,吗啡等效镇痛剂量中位数6.75(IQR 7.93)vs 未接受时10.75(IQR 12),P=0.001。
  • 接受氟哌啶醇时因胃轻瘫住院比例为5/52,未接受时为14/52,P=0.02。
  • 接受与未接受氟哌啶醇的急诊停留时间、住院时间及追加止吐药无统计学显著差异。
  • 接受氟哌啶醇的患者中未发现并发症。
  • 作者认为氟哌啶醇可能作为急诊胃轻瘫相关恶心、呕吐、腹痛传统镇痛止吐治疗的合适、有效且安全的替代选择。

适用人群与场景

  • 急诊就诊的糖尿病继发胃轻瘫相关恶心、呕吐、腹痛患者。
  • 研究纳入52例接受氟哌啶醇治疗的患者,并与本人最近一次未接受氟哌啶醇的急诊就诊对照。

研究设计与关键结果

  • 研究类型为回顾性自身对照研究,样本量52例,人群为糖尿病继发胃轻瘫相关恶心、呕吐、腹痛的急诊患者,干预为氟哌啶醇,对照为本人最近一次未接受氟哌啶醇的急诊就诊。
  • 主要终点方面,吗啡等效镇痛剂量中位数在接受氟哌啶醇时6.75(IQR 7.93)vs 未接受时10.75(IQR 12),P=0.001;因胃轻瘫住院比例在接受时5/52 vs 未接受时14/52,P=0.02。
  • 急诊停留时间、住院时间及追加止吐药在接受与未接受氟哌啶醇的就诊间无统计学显著差异。
  • 接受氟哌啶醇的患者中未发现并发症。

证据类型、等级与局限

  • 证据类型为回顾性自身对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,氟哌啶醇可能作为急诊胃轻瘫相关恶心、呕吐、腹痛的传统镇痛止吐治疗的一种合适、有效且安全的替代选择。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Gastroparesis associated nausea, vomiting & abdominal pain (GP N/V/AP) are common presentations to the emergency department (ED). Treatment is often limited to antiemetic, prokinetic, opioid, & nonopioid agents. Haloperidol (HP) has been shown to have analgesic & antiemetic properties. We sought to evaluate HP in the ED as an alternative treatment of GP N/V/AP.

METHODS: Using an electronic medical record, 52 patients who presented to the ED w/GP N/V/AP secondary to diabetes mellitus and were treated w/HP were identified. Patients who received HP were compared to themselves w/the most recent previous encounter in which HP was not administered. ED length of stay (LOS), additional antiemetics/prokinetics administered, hospital LOS, and morphine equivalent doses of analgesia (ME) from each visit were recorded. Descriptive statistics, categorical (Chi Square Test or Z-Test for proportion) and continuous (Wilcoxon Signed Rank Test) comparisons were calculated. Statistical significance was considered for two tail p-values less than 0.05.

RESULTS: A statistically significant reduction in ME (Median 6.75 [IQR 7.93] v 10.75 [IQR12]: p=0.001) and reduced admissions for GP (5/52 v 14/52: p=0.02) when HP was administered was observed. There were no statistically significant differences in ED or hospital LOS, and additional antiemetics administered between encounters in which HP was administered and not administered. No complications were identified in patients who received HP.

CONCLUSIONS: The rate of admission and ME was found to be significantly reduced in patients with GP secondary to diabetes mellitus who received HP. HP may represent an appropriate, effective, and safe alternative to traditional analgesia and antiemetic therapy in the ED management of GP associated N/V/AP.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Ramirez R, Stalcup P, Croft B, et al. Haloperidol undermining gastroparesis symptoms (HUGS) in the emergency department. Am J Emerg Med. 2017. PMID: 28320545. doi:10.1016/j.ajem.2017.03.015

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。